Nipah Virus Cases Reported in India

The World Health Organization reported on Thursday that two cases of a rare virus have emerged in an eastern Indian state.

This virus, known as Nipah, has a fatality rate exceeding 50% among those it infects. Named after the Malaysian village where it was first identified, Nipah belongs to the same family of viruses as measles. However, it’s not as easily spread, yet considerably more lethal.

Nipah is classified as a zoonotic virus. This means it can jump from animals to humans, often through direct contact with infected pigs or bats. Moreover, consuming fruit or food items, like raw date palm juice, contaminated with the urine or saliva of infected fruit bats can also facilitate its transmission.

The virus can spread between individuals, but this typically requires very close contact with an infected person.

According to WHO, symptoms can appear anywhere from four to 14 days post-infection, and it’s pretty rare for someone to be asymptomatic.

The initial signs of infection are fairly vague, resembling flu-like symptoms—such as fever, headaches, muscle aches, vomiting, and a sore throat. In roughly two-thirds of instances, the disease can escalate quickly, leading to coma within five to seven days. Some patients also exhibit respiratory symptoms, including a cough and unusual results on chest X-rays.

Most individuals experience alterations in the fluid surrounding the brain, changes that are often seen in other viral infections affecting the brain. Brain imaging can reveal these alterations due to tissue death, and the electrical activity of the brain may indicate the severity of illness.

The CDC classifies the Nipah virus as a biosafety level four pathogen—the highest level, which includes the deadliest pathogens like Ebola. Its potential as a bioterrorism agent is also noted.

Despite having seen only a few outbreaks, Nipah poses a public health risk due to its high mortality rate, the possibility of human transmission, outbreak potential, and the absence of approved vaccines or treatments.

In severe cases, it can affect areas of the brain responsible for essential life functions, such as eye movement and heart rate, leading to lasting damage.

Survivors often deal with ongoing fatigue and changes in nervous system function, with some of these effects lingering for years.

Testing typically involves analyzing a blood sample to identify specific proteins.

Currently, there are no specific vaccines or medications for Nipah. Supportive care is provided, and those with severe neurological symptoms might require assistance with breathing.

Ribavirin, a drug approved for chronic hepatitis C treatment, may have some efficacy, although the results have been mixed.

Essentially, doctors are focusing on prevention strategies to minimize the risk of animal-to-human transmission and enforce infection control protocols when dealing with infected individuals.

Nipah outbreaks are common in certain areas of Asia, particularly in Bangladesh, India, Malaysia, the Philippines, and Singapore, with Bangladesh reporting the highest number of cases. This higher incidence is likely due to the presence of large fruit bats native to these regions.

The virus generally spreads from December to May, coinciding with bat breeding and date palm sap harvesting seasons.

Nipah virus has also been detected in bats across several countries, including China, Cambodia, Thailand, Madagascar, and Ghana. Interestingly, no Nipah cases have ever been recorded in the US.

While it’s rare, about 754 cases have been documented worldwide as of 2024, although this number may be an underestimate.